FIGURE

Fig. 6.

ID
ZDB-FIG-210518-96
Publication
Oprişoreanu et al., 2021 - Automated in vivo drug screen in zebrafish identifies synapse-stabilising drugs with relevance to spinal muscular atrophy
Other Figures
All Figure Page
Back to All Figure Page
Fig. 6.

(A) Representative images of the lateral trunk of 28-30 hpf wild-type embryos. Abnormal motor neurons, i.e. short, missing or branched axons, are indicated by arrowheads. (B) The percentage of abnormal motor axons is decreased in embryos after combined treatment with UBEI-41 and dipyridamole (10 µM each) compared to those treated with UBEI-41 alone (Kruskal–Wallis test ****P<0.0001 with Dunn's multiple comparison test: ****P<0.0001, **P=0.0078 *P=0.0124, statistical power=0.999). (C) Representative images of 28-30 hpf wild-type embryos treated with DMSO, UBEI-41 or UBEI-41 and dipyridamole are shown. Abnormal axon branching is indicated by black arrowheads. Scale bars: 50 µm. (D) Quantification of axonal branching only. The number of axon branches is increased in embryos after treatment with dipyridamole (10 µM) compared to those treated with DMSO (control) (one-way ANOVA test ***P=0.0006 with Tukey's multiple comparison test: ***P=0.0007, **P=0.0062 statistical power=0.9618). All scale bars: 50 µm. Each data point represents one animal and n numbers are indicated in parenthesis. Error bars represent means±s.e.m.

Expression Data
Gene:
Fish:
Conditions:
Anatomical Term:
Stage: Prim-5

Expression Detail
Antibody Labeling
Phenotype Data
Fish:
Conditions:
Observed In:
Stage: Prim-5

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Dis. Model. Mech.